Zencoxia P 60mg/325mg Tablet is a combination analgesic and anti-inflammatory medication containing Etoricoxib 60mg and Paracetamol 325mg. Etoricoxib is a selective cyclooxygenase-2 (COX-2) inhibitor that provides effective relief from pain and inflammation by specifically targeting the COX-2 enzyme, thereby reducing the synthesis of prostaglandins involved in inflammatory processes. Paracetamol, a widely used analgesic and antipyretic agent, enhances the analgesic effect by inhibiting central prostaglandin synthesis and modulating pain perception. This combination is indicated for the management of acute and chronic musculoskeletal pain conditions such as osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and postoperative pain. Zencoxia P offers rapid and sustained pain relief while minimizing gastrointestinal side effects commonly associated with non-selective NSAIDs due to the selective action of Etoricoxib. It is essential to use this medication under medical supervision, particularly in patients with cardiovascular, hepatic, or renal impairments, as well as those with a history of gastrointestinal ulcers or bleeding. Dosage should be individualized based on the severity of symptoms and patient response, and it is advised to avoid concurrent use with other NSAIDs or hepatotoxic drugs to prevent adverse effects.